Teva was established in 1901. Our global headquarters are based in Israel. Today we have a portfolio of more than 1800 molecules, and produce approximately 120 billion tablets and capsules a year. We have over 70 manufacturing facilities in more than 30 countries.
25 R&D and clinical development sites